02:40 PM EDT, 08/05/2025 (MT Newswires) -- Syndax Pharmaceuticals ( SNDX ) shares were up over 21% in recent Tuesday trading after it posted better-than-expected Q2 financial results in the previous day.

Late Monday, the company reported Q2 loss of $0.83 per diluted share, widening from a loss of $0.80 a year earlier.

Analysts polled by FactSet expected a loss of $1.02.

Revenue for the quarter ended June 30 was $38.0 million, up from $3.5 million a year earlier.

Analysts surveyed by FactSet expected $26.8 million.

Syndax said its cash, cash equivalents, and investments would help the company reach profitability.

Price: 12.58, Change: +2.20, Percent Change: +21.15